2024 ICD-10-CM Diagnosis Code D07.39

Carcinoma in situ of other female genital organs

ICD-10-CM Code:
D07.39
ICD-10 Code for:
Carcinoma in situ of other female genital organs
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:

Code Classification

  • Neoplasms
    (C00–D49)
    • In situ neoplasms
      (D00-D09)
      • Carcinoma in situ of other and unspecified genital organs
        (D07)

D07.39 is a billable diagnosis code used to specify a medical diagnosis of carcinoma in situ of other female genital organs. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

This code is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.

The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic adnexa (uterine) ; Neoplasm, neoplastic broad ligament ; Neoplasm, neoplastic corpus ; Neoplasm, neoplastic corpus albicans ; Neoplasm, neoplastic fallopian tube (accessory) ; Neoplasm, neoplastic genital organ or tract female NEC specified site NEC ; Neoplasm, neoplastic ligament [See Also: Neoplasm, connective tissue] ; etc

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Carcinoma in situ of broad ligament
  • Carcinoma in situ of fallopian tube
  • Carcinoma in situ of ovary
  • Carcinoma in situ of parametrium
  • Carcinoma in situ of round ligament of uterus
  • Carcinoma in situ of uterine adnexa
  • Neoplasm of parametrium
  • Neoplasm of round ligament of uterus

Clinical Classification

Clinical Information

  • Broad Ligament

    a broad fold of peritoneum that extends from the side of the uterus to the wall of the pelvis.
  • Internal Hernia

    a protrusion of an internal abdominal organ through a hole in an anatomical structure such as a muscle or a membrane. for instance, in paraduodenal hernia the small intestine herniates through an opening in the mesenteries. it includes intra-abdominal and diaphragmatic hernias. in abdominal hernia a protrusion occurs through a weak spot in the muscle of the abdominal wall.

Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10-CM Code Edits are applicable to this code:

  • Diagnoses for females only - The Medicare Code Editor detects inconsistencies between a patient’s sex and any diagnosis on the patient’s record, these edits apply to FEMALES only .

Convert D07.39 to ICD-9-CM

  • ICD-9-CM Code: 233.39 - Ca in situ fem gen NEC
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Table of Neoplasms

This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »adnexa (uterine)
C57.4C79.89D07.39D28.7D39.8D49.59
»Neoplasm, neoplastic
  »broad ligament
C57.1C79.82D07.39D28.2D39.8D49.59
»Neoplasm, neoplastic
  »corpus
C56.C79.6D07.39D27.D39.1D49.59
»Neoplasm, neoplastic
  »corpus
    »albicans
C56.C79.6D07.39D27.D39.1D49.59
»Neoplasm, neoplastic
  »fallopian tube (accessory)
C57.0C79.82D07.39D28.2D39.8D49.59
»Neoplasm, neoplastic
  »genital organ or tract
    »female NEC
      »specified site NEC
C57.7C79.82D07.39D28.7D39.8D49.59
»Neoplasm, neoplastic
  »ligament [See Also: Neoplasm, connective tissue]
C57.1C79.82D07.39D28.2D39.8D49.59
»Neoplasm, neoplastic
  »ligament [See Also: Neoplasm, connective tissue]
    »broad
C57.1C79.82D07.39D28.2D39.8D49.59
»Neoplasm, neoplastic
  »ligament [See Also: Neoplasm, connective tissue]
    »Mackenrodt's
C57.7C79.82D07.39D28.7D39.8D49.59
»Neoplasm, neoplastic
  »ligament [See Also: Neoplasm, connective tissue]
    »utero-ovarian
C57.7C79.82D07.39D28.2D39.8D49.59
»Neoplasm, neoplastic
  »Mackenrodt's ligament
C57.7C79.82D07.39D28.7D39.8D49.59
»Neoplasm, neoplastic
  »mesosalpinx
C57.1C79.82D07.39D28.2D39.8D49.59
»Neoplasm, neoplastic
  »mesovarium
C57.1C79.82D07.39D28.2D39.8D49.59
»Neoplasm, neoplastic
  »Mullerian duct
C57.7C79.82D07.39D28.7D39.8D49.59
»Neoplasm, neoplastic
  »Mullerian duct
    »female
C57.7C79.82D07.39D28.7D39.8D49.59
»Neoplasm, neoplastic
  »ovary
C56.C79.6D07.39D27.D39.1D49.59
»Neoplasm, neoplastic
  »oviduct
C57.0C79.82D07.39D28.2D39.8D49.59
»Neoplasm, neoplastic
  »paroophoron
C57.1C79.82D07.39D28.2D39.8D49.59
»Neoplasm, neoplastic
  »parovarium
C57.1C79.82D07.39D28.2D39.8D49.59
»Neoplasm, neoplastic
  »salpinx (uterine)
C57.0C79.82D07.39D28.2D39.8D49.59
»Neoplasm, neoplastic
  »tubo-ovarian
C57.8C79.82D07.39D28.7D39.8D49.59
»Neoplasm, neoplastic
  »utero-ovarian
C57.8C79.82D07.39D28.7D39.8D49.59
»Neoplasm, neoplastic
  »utero-ovarian
    »ligament
C57.1C79.82D07.39D28.2D39.8D49.59
»Neoplasm, neoplastic
  »uterus, uteri, uterine
    »adnexa NEC
C57.4C79.82D07.39D28.7D39.8D49.59
»Neoplasm, neoplastic
  »uterus, uteri, uterine
    »ligament
      »broad
C57.1C79.82D07.39D28.2D39.8D49.59
»Neoplasm, neoplastic
  »uterus, uteri, uterine
    »tube
C57.0C79.82D07.39D28.2D39.8D49.59
»Neoplasm, neoplastic
  »wolffian (body) (duct)
C57.7C79.82D07.39D28.7D39.8D49.59
»Neoplasm, neoplastic
  »wolffian (body) (duct)
    »female
C57.7C79.82D07.39D28.7D39.8D49.59

Patient Education


Cancer

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Most treatment plans may include surgery, radiation and/or chemotherapy. Some may involve hormone therapy, immunotherapy or other types of biologic therapy, or stem cell transplantation.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.